MN1 and acute myeloid leukemia: In the inv(16) AML subgroup, the patient who remained in continuous complete remission (CCR) constantly showed MN1 values within the normal range (Table 3), whereas the five patients who ultimately relapsed showed a progressive raising of MN1 levels above the normal range during hematological remission (Table 3 and Figure 3).